China has released its first national policy document aimed at advancing the marine biopharmaceutical industry. The guidance emphasizes integrating resource, technology, industry, and application chains to foster innovation. The goal is to have multiple marine innovative drugs on the market by 2030, with the industry's added value exceeding 130 billion yuan. AI
IMPACT This policy aims to boost innovation in marine pharmaceuticals, potentially leading to new drug discoveries and economic growth in a specialized sector.
RANK_REASON First national policy document for a specific industry. [lever_c_demoted from significant: ic=1 ai=0.1]
AI-generated summary · Google Gemini · from 1 sources. How we write summaries →